NCT06076213View on ClinicalTrials.gov

Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the Congo

PHASE4CompletedINTERVENTIONAL
Enrollment

1,260

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

September 24, 2024

Study Completion Date

September 30, 2024

Conditions
Uncomplicated Plasmodium Falciparum Malaria
Interventions
DRUG

Artesunate-amodiaquine

Tablets

DRUG

Artemether-lumefantrine

Tablets

Trial Locations (7)

Unknown

Centre de santé de Coopération, Kimpese

Centre de santé Lupidi 1, Kapolowe

Centres de santé de Mikalayi et Matamba, Kazumba

Centre de Santé de Vanga, Vanga

Centre de santé de Kalima, Kalima

Centres de santé Umoja et Foyer social, Kabondo

Centre de santé Boende 2 Nsele, Boende

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

Global Fund

OTHER

lead

Ministry of Public Health, Democratic Republic of the Congo

OTHER_GOV

NCT06076213 - Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the Congo | Biotech Hunter | Biotech Hunter